AstraZeneca PLC is 19.9x more valuable than Jazz Pharmaceuticals plc by market capitalization ($286.27 B vs $14.41 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | JAZZ | AZN |
|---|---|---|
| Market cap | $14.41 B | $286.27 B |
| US-listed rank | #749 | #45 |
| Revenue (latest FY) | $4.27B | - |
| Net income (latest FY) | -$356.15M | - |
| Net margin | -8.3% | - |
| SEC filings | 2,093 | 1,004 |
AstraZeneca PLC is 19.9x more valuable than Jazz Pharmaceuticals plc by market capitalization ($286.27 B vs $14.41 B).
Full pages: Jazz Pharmaceuticals plc and AstraZeneca PLC, or browse the full rankings.